Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 9/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 7/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 7/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 6/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5730673 | 0.90 | ADRA1A (0.44) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5729745 | 0.88 | ADRA1A (0.45) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5730983 | 0.84 | ADRA1A (0.45) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5730482 | 0.84 | ADRA1A (0.48) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5731220 | 0.83 | ADRA1A (0.47) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5729362 | 0.82 | ADRA1A (0.47) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5730355 | 0.81 | ADRA1A (0.44) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5730989 | 0.81 | ADRA1A (0.47) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5729739 | 0.80 | ADRA1A (0.46) | ADRA1AADRA1DADRA1BADRA2CADRA2A | |
| SCHEMBL5730950 | 0.80 | ADRA1A (0.44) | ADRA1AADRA1DADRA1BADRA2CADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100378095-C | Substituted indoles as alpha-1 agonists | HOFFMANN LA ROCHE (CH) | 2008-04-02 | — | — | CN | disclosed |
| EP-1501826-B1 | SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS | HOFFMANN LA ROCHE (CH) | 2006-09-27 | — | — | EP | disclosed |
| CN-1628113-A | Substituted indoles as alpha-1 agonists | HOFFMANN LA ROCHE (CH) | 2005-06-15 | — | — | CN | disclosed |
| EP-1501826-A2 | SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS | F. Hoffman-la Roche AG (CH) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003064387-A2 | SUBSTITUTED INDOLES AS ALPHA-1 AGONISTS | F. HOFFMAN-LA ROCHE AG (CH) | 2003-08-07 | — | — | WO | disclosed |